Attached files
| file | filename |
|---|---|
| 10-K/A - 10-K/A - Frazier Lifesciences Acquisition Corp | d13011d10ka.htm |
| EX-32.1 - EX-32.1 - Frazier Lifesciences Acquisition Corp | d13011dex321.htm |
| EX-31.2 - EX-31.2 - Frazier Lifesciences Acquisition Corp | d13011dex312.htm |
| EX-31.1 - EX-31.1 - Frazier Lifesciences Acquisition Corp | d13011dex311.htm |
| EX-4.2 - EX-4.2 - Frazier Lifesciences Acquisition Corp | d13011dex42.htm |
Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Frazier Lifesciences Acquisition Corporation (the “Company”) on Form 10-K for the period ending December 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, David Topper, in my capacity as Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: May 24, 2021 | By: | /s/ David Topper | ||
| Name: | David Topper | |||
| Title: | Chief Financial Officer and Director (Principal Financial and Accounting Officer) |